185 related articles for article (PubMed ID: 14632053)
1. Syntheses of immobilized G protein-coupled receptor chromatographic stationary phases: characterization of immobilized mu and kappa opioid receptors.
Beigi F; Wainer IW
Anal Chem; 2003 Sep; 75(17):4480-5. PubMed ID: 14632053
[TBL] [Abstract][Full Text] [Related]
2. G-protein-coupled receptor chromatographic stationary phases. 2. Ligand-induced conformational mobility in an immobilized beta2-adrenergic receptor.
Beigi F; Chakir K; Xiao RP; Wainer IW
Anal Chem; 2004 Dec; 76(24):7187-93. PubMed ID: 15595859
[TBL] [Abstract][Full Text] [Related]
3. The region in the mu opioid receptor conferring selectivity for sufentanil over the delta receptor is different from that over the kappa receptor.
Zhu J; Xue JC; Law PY; Claude PA; Luo LY; Yin J; Chen C; Liu-Chen LY
FEBS Lett; 1996 Apr; 384(2):198-202. PubMed ID: 8612823
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells.
Hirota K; Okawa H; Appadu BL; Grandy DK; Devi LA; Lambert DG
Anesthesiology; 1999 Jan; 90(1):174-82. PubMed ID: 9915326
[TBL] [Abstract][Full Text] [Related]
5. Effects of sigma ligands on the cloned mu-, delta- and kappa-opioid receptors co-expressed with G-protein-activated K+ (GIRK) channel in Xenopus oocytes.
Kobayashi T; Ikeda K; Ichikawa T; Togashi S; Kumanishi T
Br J Pharmacol; 1996 Sep; 119(1):73-80. PubMed ID: 8872359
[TBL] [Abstract][Full Text] [Related]
6. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.
Pogozheva ID; Lomize AL; Mosberg HI
Biophys J; 1998 Aug; 75(2):612-34. PubMed ID: 9675164
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors.
Xu W; Li J; Chen C; Huang P; Weinstein H; Javitch JA; Shi L; de Riel JK; Liu-Chen LY
Biochemistry; 2001 Jul; 40(27):8018-29. PubMed ID: 11434771
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors.
Chen Y; Mestek A; Liu J; Yu L
Biochem J; 1993 Nov; 295 ( Pt 3)(Pt 3):625-8. PubMed ID: 8240267
[TBL] [Abstract][Full Text] [Related]
9. Opioid receptor types and subtypes: the delta receptor as a model.
Zaki PA; Bilsky EJ; Vanderah TW; Lai J; Evans CJ; Porreca F
Annu Rev Pharmacol Toxicol; 1996; 36():379-401. PubMed ID: 8725395
[TBL] [Abstract][Full Text] [Related]
10. [Binding characteristics of new synthesized opioid receptor ligands to cloned mu opioid receptors stably expressed in CHO cell].
Hu P; Ye CY; Qiu ZB; Yang HF; Zhang DC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Feb; 25(1):79-82. PubMed ID: 12905615
[TBL] [Abstract][Full Text] [Related]
11. The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors.
Xu W; Chen C; Huang P; Li J; de Riel JK; Javitch JA; Liu-Chen LY
Biochemistry; 2000 Nov; 39(45):13904-15. PubMed ID: 11076532
[TBL] [Abstract][Full Text] [Related]
12. Expression of the mu-opioid receptor in CHO cells: ability of mu-opioid ligands to promote alpha-azidoanilido[32P]GTP labeling of multiple G protein alpha subunits.
Chakrabarti S; Prather PL; Yu L; Law PY; Loh HH
J Neurochem; 1995 Jun; 64(6):2534-43. PubMed ID: 7760033
[TBL] [Abstract][Full Text] [Related]
13. Expression of opioid and anti-opioid receptors in Chinese hamster ovary cells after exposure to dimethyl sulfoxide.
Talmont F; Mollereau C; Zajac JM
Anal Biochem; 2012 Jan; 420(1):99-100. PubMed ID: 21951781
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and opioid activity of enantiomeric N-substituted 2,3,4,4a,5,6,7,7a-octahydro-1H-benzofuro[3,2-e]isoquinolines.
Hsin LW; Chang LT; Rothman RB; Dersch CM; Fishback JA; Matsumoto RR
J Med Chem; 2010 Feb; 53(3):1392-6. PubMed ID: 20055417
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
16. Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane.
Zhang P; Johnson PS; Zöllner C; Wang W; Wang Z; Montes AE; Seidleck BK; Blaschak CJ; Surratt CK
Brain Res Mol Brain Res; 1999 Oct; 72(2):195-204. PubMed ID: 10529478
[TBL] [Abstract][Full Text] [Related]
17. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
[TBL] [Abstract][Full Text] [Related]
18. Development of an immobilized GPR17 receptor stationary phase for binding determination using frontal affinity chromatography coupled to mass spectrometry.
Temporini C; Ceruti S; Calleri E; Ferrario S; Moaddel R; Abbracchio MP; Massolini G
Anal Biochem; 2009 Jan; 384(1):123-9. PubMed ID: 18835238
[TBL] [Abstract][Full Text] [Related]
19. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
[TBL] [Abstract][Full Text] [Related]
20. Localization of opioid receptor antagonist [3H]-LY255582 binding sites in mouse brain: comparison with the distribution of mu, delta and kappa binding sites.
Gackenheimer SL; Suter TM; Pintar JE; Quimby SJ; Wheeler WJ; Mitch CH; Gehlert DR; Statnick MA
Neuropeptides; 2005 Dec; 39(6):559-67. PubMed ID: 16289278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
